U.S. agency widens generic-drug probe
The U.S. Federal Trade Commission is making a big push to expand its probe of giants in the pharmaceutical industry to determine whether they are unfairly stiffling generic competition. The agency's
The U.S. Federal Trade Commission is making a big push to expand its probe of giants in the pharmaceutical industry to determine whether they are unfairly stiffling generic competition. The agency's